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Salmonella pathogenicity island 1 (SPI-1) encodes virulence determinants, which are important for entero-
pathogenicity in calves. To determine whether the Salmonella enterica serovar Typhimurium SPI-1 effector
proteins SspA and SptP are important for enteropathogenicity, strains lacking these proteins were tested
during oral infection of calves. Calves infected with a sptP mutant or its isogenic parent developed diarrhea and
lethal morbidity. In contrast, calves infected with an sspA mutant developed diarrhea, which resolved within 10
days but did not result in mortality. The sspA mutant was recovered from bovine intestinal tissues at numbers
similar to those obtained for its isogenic parent and caused marked intestinal lesions. Thus, the severity of
pathological changes caused by serovar Typhimurium strains or their ability to cause diarrhea were not
predictive of their ability to cause lethal morbidity in calves. We conclude that factors other than or in addition
to bacterial colonization, intestinal lesions, or electrolyte loss contribute to lethal morbidity in calves infected
with serovar Typhimurium.
The incidence of human salmonellosis is estimated to range
between 800,000 and 3,700,000 cases per year in the United
States (7). Each year, approximately 40,000 cases are serotyped
and reported to the Centers for Disease Control and Preven-
tion (6). The incidence of reported Salmonella infections in the
United States is highest among children aged less than 1 year,
with 111 cases per 100,000 population (5). Between 21 and
38% of human salmonellosis cases in North America and Eu-
rope are due to infection with a single serovar, Salmonella
enterica serovar Typhimurium (4, 20, 37). Serovar Typhi-
murium infections in humans commonly remain localized to
the intestine and draining lymph nodes and manifest within
48 h after ingestion of contaminated food or water with nausea,
vomiting, and acute diarrhea which progresses toward dysen-
tery (30). Since serovar Typhimurium usually causes a self-
limited infection with diarrhea resolving within 10 days, re-
placement of fluids and electrolytes is the primary approach to
treatment (23). Serovar Typhimurium produces bacteremia in
1.1% of patients (37), and in these cases antibiotic therapy can
be lifesaving. The testing of S. typhimurium isolates for antibi-
otic sensitivity has shown that in recent years, an increasing
proportion is resistant to multiple antimicrobial agents (14).
The continuing epidemic of multidrug-resistant serovar Typhi-
murium will likely reduce the efficacy of antibiotic therapy in
the future. In order to devise alternate strategies for the con-
trol of salmonellosis, it will be necessary to develop a better
understanding of the fundamental factors that serovar Typhi-
murium uses to cause morbidity and mortality.
In addition to its association with human disease, serovar
Typhimurium is a major cause of calf morbidity and mortality
in the United States and in Europe (29, 32). A survey per-
formed in Britain revealed that Salmonella serovars are asso-
ciated with 12% of diarrhea outbreaks among calves (28). Two
serotypes, Typhimurium and Dublin, are associated with more
than 95% of the salmonellosis cases reported from cattle (13,
34, 35). Since bovine enteritis closely resembles the illness
produced by serovar Typhimurium in humans, recent studies
have focused on experimental oral infection of calves to estab-
lish an animal model for diarrheal disease in humans (38, 40).
Approximately 75% of serovar Typhimurium infections occur
in calves less than 2 months of age, before the animals are
weaned (34). Calves inoculated orally with serovar Typhi-
murium develop diarrhea within 48 h (27), while the infection
remains primarily enteric, with only occasional bacteremia
(43). Oral inoculation of calves at a dose of 105 to 107 organ-
isms usually results in a transient diarrhea which resolves
within 10 days, but oral inoculation at higher doses may lead to
mortality (33, 43). Lethal signs of disease in calves include
anorexia and central nervous system depression (33). At nec-
ropsy, calves infected with a lethal dose of serovar Typhi-
murium present with marked intestinal lesions. These include
acute fibrinopurulent necrotizing enteritis with pseudomem-
brane deposition at the luminal surface of the terminal 5 m of
the ileum and the cranial 1 to 2 m of the colon. Furthermore,
serovar Typhimurium infection results in lymphoid depletion
in germinal centers of intestinal lymphoid follicles and in the
mesenteric lymph node (38, 43). Although severe intestinal
lesions, acute diarrhea, and the resulting dehydration are strik-
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ing features of bovine enteritis, it is not clear whether these
signs of disease contribute to mortality in calves.
Several studies have implicated the invasion-associated type
III secretion system encoded by Salmonella pathogenicity is-
land 1 (SPI-1) in causing diarrhea and mortality in cattle. For
instance, mutations in prgH, hilA, and invH, three genes lo-
cated on SPI-1, result in strongly reduced diarrhea and marked
attenuation of serovar Typhimurium during oral infection of
calves (38, 40). Furthermore, SPI-1 mutants of serovars Dublin
and Typhimurium elicit reduced fluid accumulation and neu-
trophil influx in bovine ligated ileal loops (1, 12). However, the
mechanisms by which SPI-1 promotes enteropathogenicity are
unknown.
The main function of the type III secretion system encoded
by SPI-1 is to translocate bacterial effector proteins into the
cytosol of the host cell. Some of the effector proteins translo-
cated by the invasion associated type III secretion system are
encoded by genes that are not located on SPI-1. For example
SopB (also known as SigD), a protein with inositol phosphate
phosphatase activity, is translocated into epithelial cells by an
SPI-1-dependent pathway (12, 24). The sopB gene is located on
SPI-5, and mutational inactivation results in a modest reduc-
tion of fluid secretion elicited by serovar Dublin in bovine
ligated ileal loops (12, 41). However, unlike strains carrying a
mutation in hilA or prgH, a serovar Typhimurium sopB mutant
causes severe diarrhea and mortality at wild-type levels during
oral infection of calves (38). These data suggest that in addi-
tion to SopB, other SPI-1-secreted effector proteins play a role
in enteropathogenicity.
Genes located on SPI-1 encode eight secreted targets of the
invasion-associated type III export apparatus, including InvJ
(SpaN), SpaO, AvrA, SptP, SspA (SipA), SspB (SipB), SspC
(SipC), and SspD (SipD) (9–11, 15, 17–19). Five of these tar-
gets, AvrA, SptP, SspA, SspB, and SspC, are translocated into
epithelial cells and may thus be considered secreted effector
proteins (8, 9, 15, 44). The SspB protein has two functions. It
is an effector protein which, after injection into macrophages,
causes apoptosis by binding to caspase-1 (16). In addition,
SspB is part of a translocation apparatus (formed by SspB,
SspC, and SspD) which is required for the delivery of secreted
effector proteins (e.g., SptP, AvrA, SopB, SopE, SspB, and
SspC) into the eukaryotic cytoplasm (8, 11, 12, 15, 42). Inac-
tivation of sspB results in a dramatic reduction in fluid secre-
tion and polymorphonuclear cell influx elicited by serovar
Dublin in bovine ligated ileal loops (12). However, since a
mutation in sspB prevents translocation of a number of targets
of the invasion-associated type III secretion system, it is not
clear which secreted effector proteins are responsible for this
phenotype. Furthermore, it is not apparent from results ob-
tained using the ligated ileal loop assay how a mutation may
effect other aspects of disease, including the severity of intes-
tinal lesions or lethality (38). To determine the role of individ-
ual SPI-1-secreted effector proteins in producing virulence-
associated phenotypes, such as diarrhea, intestinal lesions, or
lethality, we have investigated the effect of mutations in sspA
and sptP on enteropathogenicity during oral infection of sero-
var Typhimurium in calves.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Derivatives of ATCC strain 14028, a
bovine serovar Typhimurium isolate, are listed in Table 1. Strain IR715 is a
spontaneous nalidixic acid-resistant derivative of 14028 (36). Strain CS401 is a
spontaneous streptomycin-resistant (Strr) derivative of 14028 which carries a
phoN::Tn10d(Cm) insertion (26). Bacteria were cultured aerobically at 37°C in
Luria-Bertani (LB) broth (per liter, 10 g of tryptone, 5 g of yeast extract, and 10 g
of NaCl) or on LB agar (16 g/liter) plates. If appropriate, antibiotics were added
at the following concentrations: kanamycin, 100 mg/liter; chloramphenicol, 30
mg/liter; ampicillin, 100 mg/liter; streptomycin, 100 mg/liter; nalidixic acid, 50
mg/liter.
Construction of mutants. A nonpolar deletion of the prgHIJK operon was
constructed by allelic exchange. DNA fragments of approximately 1 kb originat-
ing upstream and downstream of prgH and prgK, respectively, were amplified by
PCR. The fragment upstream of the deletion contained the first 15 nucleotides
of prgH, while the downstream fragment contained the last 192 nucleotides of
prgK. The upper and lower flanking regions were ligated together in plasmid
pKAS32, a lpir-dependent suicide vector encoding resistance to ampicillin and
an rpsL allele conferring streptomycin sensitivity (32), to generate pTK62. Plas-
mid pTK62 was introduced into Escherichia coli strain Sm10lpir and transferred
into Salmonella serovar Typhimurium strain CS401 by conjugation. Exconjugants
containing pTK62 integrated into the serovar Typhimurium chromosome were
selected on LB agar plates supplemented with ampicillin and chloramphenicol.
Deletion of the rpsL allele of plasmid pTK62 by a second recombination event
was selected for by plating exconjugants on LB agar plates containing strepto-
mycin. An Strr isolate (TK091) containing the prgHIJK deletion was identified by
Southern blot analysis using a 4,307-bp DNA probe containing the prgHIJK
operon. Using the above strategy, a nonpolar deletion of sptP was constructed by
digesting a cloned 5.5-kb BamHI DNA fragment containing sptP with EcoRV
and AflII. Religation of the plasmid resulted in a 1,737-bp deletion which re-
moved sequences 247 bp upstream of the sptP start codon to 50 bp downstream
of the codon for the conserved active-site cysteine of SptP. Following integration
of a suicide vector containing the 1,736-bp deletion and streptomycin treatment,
an ampicillin-sensitive Strr isolate (MJH2362) was analyzed by Southern hybrid-
ization using the 5.5-kb BamHI fragment as a probe. Nonpolar deletions of sspB
and sspD were constructed using the same strategy. Regions approximately 1 kb
directly upstream and downstream of the coding sequences of each gene were
PCR amplified. The upper and lower flanking regions were ligated together in
pKAS32 to generate pMM02 (sspB deletion vector) and pMM04 (sspD deletion
vector). These plasmid were introduced into CS401 by conjugative transfer, and
exconjugants were selected for by growth on LB agar plates containing ampicillin
and chloramphenicol. Deletion of plasmid sequences was induced by growth on
LB agar plates supplemented with streptomycin, and clones containing the de-
letions were identified by Southern blot analysis using a DNA probe specific to
sspC. The resultant clones contained a complete deletion of the sspB coding
sequence (CAS152) and a deletion of the sspD coding sequence through the
HindIII site at nucleotide 1013 (CAS153). The lack of SspB and SspD expression
was confirmed by Western blot analysis (data not shown) with trichloroacetic
acid precipitates of culture supernatants and whole cell lysates of bacterial
cultures (grown to an optical density at 600 nm of 1.2 to 1.5), using antibodies
generated to secreted proteins as described previously (17).
Animal experiments. Milk-fed male Friesian/Holstein calves, aged 3 to 4
weeks, were obtained from a commercial dairy calf rearing operation. The weight
of the calves ranged between 45 and 52 kg. Animals were cared for according to
Association for Assessment and Accreditation of Laboratory Animal Care guide-
lines. Calves were fed 2 liters of milk replacer twice daily and were given water
ad libitum. Before being used for experiments, calves were screened for elevated
white blood cell counts, fever, and infection with Salmonella serovars. Salmonella
serovars were detected in fecal swabs by enrichment in tetrathionate broth
(Difco) and plating on brilliant green agar (BBL).
Oral infection of bull calves was performed as described previously (22). In
brief, the optical density of overnight cultures at 600 nm was determined to
estimate the number of bacteria per milliliter. A volume containing the desired
numbers of bacteria was added to 50 ml of a suspension of 5% magnesium
trisilicate, 5% sodium bicarbonate, and 5% magnesium carbonate buffer. The
inoculum was added to 950 ml of milk replacer and fed orally to calves. Serial
10-fold dilutions of the inoculum were spread on LB plates to determine the
exact number of CFU fed to each animal.
TABLE 1. Derivatives of serovar Typhimurium strain
ATCC 14028 used in this study
Strain Genotype Reference
IR715 14028 wild type, nalidixic
acid resistant
36
CS401 14028 phoN::Tn10d(Cm)
Strr
26
MJH2362 CS401 DsptP This study
EE633 CS401 sspA::Tn5lacZY 3
CAS152 CS401 DsspB This study
CAS108 CS401 DsspC C. A. Scherer, E. Cooper,
and S. I. Miller,
submitted for
publication
CAS153 CS401 DsspD This study
TK091 CS401 DprgH–K This study
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A previous report indicates that in calves which survive a serovar Typhimurium
infection, diarrhea does not persist beyond the day 10 postinfection (27). Calves
were hence monitored for 10 days postinfection and then euthanized. When
calves developed anorexia or were unable to stand, they were euthanized for
humane reasons as described previously (22). Weights and fecal scores (assess-
ment of diarrhea) of calves were recorded daily. Shedding of serovar Typhi-
murium was monitored by taking daily rectal swabs, subsequent enrichment in
tetrathionate broth (Difco), and plating on brilliant green agar (BBL). Blood
samples were taken before (two samples taken on different days) and at 1 and 2
days after infection. Determination of concentrations of sodium, chloride, glu-
cose, blood urea nitrogen, creatinine, aspartate transaminase, alkaline phospha-
tase, creatinine kinase, phosphorus, albumen, anion gap, total calcium, total
protein, and total bilirubin in plasma samples was performed by Clinical Pathol-
ogy Ektachem (Texas Veterinary Medical Center, Texas A&M University). The
normal range of blood values was determined from 56 blood samples taken prior
to infection from 28 calves (two blood samples were taken from each calf on two
separate days).
During competitive infection experiments, groups of four calves were inocu-
lated at a total dose of approximately 109 CFU/animal with a 1:1 mixture of
wild-type and mutant bacteria. At 4 days postinfection, animals were euthanized.
Tissues were collected, homogenized in phosphate-buffered saline, and plated in
the presence of the appropriate antibiotics for enumeration of mutant and
wild-type bacteria to determine the output ratio. Data were normalized by
dividing the wild type/mutant output ratio of by the wild type/mutant input ratio.
All data were converted logarithmically prior to the calculation of averages and
statistical analysis. Student’s t test was used to determine whether the wild
type/mutant ratio recovered from infected organs was significantly different from
the wild type/mutant ratio present in the inoculum.
To evaluate the effect of fluid and electrolyte replacement, four calves were
each infected with approximately 1010 CFU of serovar Typhimurium strain
IR715. Two calves were given 1 liter of rehydration solution (90 mM sodium, 20
mM potassium, 80 mM chloride, 30 mM bicarbonate, 111 mM glucose) intra-
gastrically through a feeding tube three times daily. Blood values were taken
prior to infection and on days 1 and 2 postinfection. The experiment was re-
peated with four calves, two of which received oral rehydration therapy.
Histopathology. Calves infected with approximately 1010 CFU of mutant or
wild-type bacteria were euthanized at identical time points postinfection to allow
direct comparison of the histopathological lesions. Euthanasia and preparation
of tissue samples for histopathology were performed as described previously
(22). At necropsy, tissue samples from Peyer’s patches, ileum, and mesenteric
lymph node were collected; a portion was homogenized in phosphate-buffered
saline and plated in the presence of the appropriate antibiotics for enumeration
of bacteria. The remaining tissue samples were coded for blind examination.
Tissue samples were fixed in 10% formalin, embedded in paraffin, thin sectioned,
and stained with hematoxylin and eosin for histopathological examination.
RESULTS
Role of SPI-1 effector genes in calf virulence. Calves infected
with 1010 CFU of strain CS401, a wild-type derivative marked
by insertion of an antibiotic resistance cassette into the phoN
gene, had aqueous diarrhea with feces containing various com-
binations of blood, fibrin, and mucus. All calves developed
signs of terminal illness (anorexia or inability to stand) be-
tween days 2 and 5 postinfection and were euthanized (Fig. 1).
In contrast, mutations which are known to prevent type III
secretion (phoN DprgHIJK) or translocation of effector pro-
teins into host cells (DsspB, DsspC, or DsspD) resulted in
marked attenuation. Calves infected with 1010 CFU of strain
CAS152 (phoN DsspB), CAS108 (phoN DsspC), CAS153 (phoN
DsspD), or TK091 (phoN DprgHIJK) either had only soft feces
for 3 to 4 days or normal feces. After 10 days, all calves were
healthy. These data confirm previous reports that mutations in
prgH or hilA, which inactivate the SPI-1-encoded type III se-
cretion system, reduce the severity of diarrhea and cause
marked attenuation during serovar Typhimurium infection in
calves (38). To assess the role in calf virulence of SPI-1 effector
proteins, which are not required for protein translocation,
groups of four animals were infected orally with 1010 CFU of
strain MJH2362 (phoN sptP) or EE633 (phoN sspA). In both
groups, all calves developed aqueous diarrhea comparable to
that caused by their isogenic parent (CS401). The sptP mutant
(MJH2362) caused lethal morbidity in three of four infected
calves. In calves infected with the sspA mutant (EE633), the
diarrhea resolved within 10 days and all animals recovered
from the infection.
To assess the severity of clinical signs of disease quantita-
tively, we determined how the composition of blood changes
during infection. Blood was collected from calves before infec-
tion and at day 2 after infection. This time point was chosen
because calves infected with strain CS401 (phoN) developed
signs of terminal illness starting at day 2 postinfection and were
FIG. 1. Enteropathogenicity of serovar Typhimurium SPI-1 mutants. Graphs
show the difference in the plasma concentrations of sodium (top), total calcium
(middle), and total bilirubin (bottom) determined for samples collected 2 days
postinfection relative to a preinfection sample. Each circle represents data from
an individual animal. Open circles indicate plasma values which were within the
normal range of 133 to 143 mM (sodium), 9.1 to 10.6 mg/dl (total calcium), or 0.2
to 1.0 mg/dl (total bilirubin); closed circles indicate plasma values outside the
normal range. The ability of serovar Typhimurium strains to cause lethal infec-
tion and diarrhea is shown below.
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euthanized. The sodium concentration in plasma of animals
that developed diarrhea was decreased at day 2 postinfection
and was below the normal range of 133 to 141 mM in 9 out of
12 animals with diarrhea (Fig. 1). The plasma concentration of
sodium did not decrease notably in calves, which did not de-
velop diarrhea. The decrease in the plasma sodium concentra-
tion in calves infected with strain CS401 (phoN), MJH2362
(phoN sptP), or EE633 (phoN sspA) was likely caused by elec-
trolyte loss due to intestinal fluid secretion. These data thus
confirmed that calves infected with CS401 (phoN), MJH2362
(phoN sptP), or EE633 (phoN sspA) developed diarrhea of
similar severity.
The amount of total calcium decreased in calves with diar-
rhea and was below the normal range of 9.1 to 10.5 mg/dl at
day 2 postinfection in all animals infected with strain CS401
(phoN), MJH2362 (phoN sptP), or EE633 (phoN sspA) (Fig. 1).
In contrast, the plasma concentration of calcium stayed within
the normal range in all calves that did not develop diarrhea. A
decrease in the total calcium concentrations may be the result
of a diarrhea-induced loss of plasma proteins, which bind cal-
cium. A decrease in the plasma protein content in serovar
Typhimurium-infected calves with severe diarrhea has been
reported previously (33). Similarly, we found that the total
protein content of plasma tended to decrease in calves with
severe diarrhea but stayed within the normal range of 5.0 to 7.1
g/dl in all calves.
The amount of total bilirubin increased in all calves infected
with strain CS401 (phoN), MJH2362 (phoN sptP), or EE633
(phoN sspA) and was above the normal range of 0.3 to 1.0
mg/dl in 10 out of 12 animals with diarrhea (Fig. 1). The
amount of total bilirubin remained within the normal range in
animals infected with strain CAS152 (phoN DsspB), CAS108
(phoN DsspC), CAS153 (phoN DsspD), or TK091 (phoN
DprgHIJK). The reason for the increase in the concentration of
total bilirubin in animals infected with strain CS401 (phoN),
MJH2362 (phoN sptP), or EE633 (phoN sspA) is unclear.
Ability of serovar Typhimurium mutants to colonize bovine
intestinal tissue and cause lesions. To assess the effect of
mutations in sptP and sspA on invasion of the intestinal mucosa
in calves, each strain was tested for its ability to compete with
serovar Typhimurium strain IR715 (nalidixic acid-resistant
wild type) for colonization of bovine tissues. Groups of four
calves were infected orally with a 1:1 mixture of wild type
(IR715) and one mutant. Four days postinfection, calves were
euthanized and organs (ileum, Peyer’s patch, and mesenteric
lymph node) were collected. The resistance marker of the
phoN::Tn10d(Cm) allele was used to distinguish the CS401
derivatives from the competing wild-type strain (IR715). A
competitive infection of strain CS401(phoN) and strain IR715
revealed that strain CS401 displayed a modest defect in com-
petitive colonization (IR715 was recovered in approximately
fivefold-higher numbers than CS401) (Fig. 2). The colonization
defect of CS401 may be due either to its phoN mutation or to
the mutation leading to streptomycin resistance, but this was
not further investigated. Mutations in sptP (MJH2362) or sspA
(EE633) did not further reduce the ability of a phoN mutant to
colonize bovine intestinal tissues (Fig. 2). To compare these
results with a colonization defect caused by inactivation of the
type III secretion/translocation machinery, competitive infec-
tions with IR715 were performed with strain CAS152 (phoN
DsspB), CAS108 (phoN DsspC), or CAS153 (phoN DsspD). The
wild type (IR715) was recovered in approximately 500- to
1,000-fold-higher numbers from bovine Peyer’s patches than
CAS152, CAS108, or CAS153. This observation is consistent
with a previous report that during competitive infection exper-
iments, the serovar Typhimurium wild type is recovered in 500-
to 5,000-fold-higher numbers from bovine Peyer’s patches than
strains carrying mutations in hilA or prgH, two genes required
for SPI-1 dependent type III secretion (39). Thus, sspB, sspC,
or sspD, but not sptP or sspA, is required for colonization of the
bovine intestine by serovar Typhimurium. Furthermore, there
was a good correlation between the ability of a strain to invade
the intestinal mucosa (Fig. 2) and its ability to cause diarrhea
in calves (Fig. 1).
To determine whether attenuation of the sspA mutant is
related to the severity of intestinal lesions caused by this strain,
two calves were infected either with CAS152 (phoN sspB),
EE633 (phoN sspA), or their isogenic parent (CS401). One calf
in each group was euthanized at days 1 and 2 postinfection. At
necropsy, gross pathologic examination was performed and
tissue samples from Peyer’s patches, ileum, and mesenteric
lymph node were collected for histopathologic examination.
Strains EE633 (phoN sspA) and its isogenic parent (CS401)
produced macroscopically severe acute fibrinopurulent necro-
tizing enteritis with segmental or continuous pseudomembrane
deposition. No gross pathological lesions were detected in
calves infected with CAS152 (phoN DsspB). Histopathologic
analysis revealed severe lymphoid depletion and confirmed the
FIG. 2. Ability of serovar Typhimurium mutants to compete with a nalidixic acid-resistant wild-type strain (IR715) for colonization of bovine tissues. For each
mutant, competitive infection was studied with groups of four animals infected with a 1:1 mixture of wild-type (IR715) and mutant bacteria. The wild type/mutant ratio
recovered from organs of infected calves 4 days postinfection is shown as mean (bars) 6 standard deviation. MLN, mesenteric lymph node; PP, ileal Peyer’s patch
proximal to cecum; IL, terminal ileum.
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severe acute fibrinopurulent necrotizing enteritis in calves in-
fected with EE633 (phoN sspA) or CS401 (phoN) (data not
shown). Intestinal lesions were either negligible or absent in
calves infected with CAS152 (phoN DsspB). Thus, the severity
of intestinal lesions correlated with the ability of a mutant to
colonize bovine intestinal tissues during a competitive infec-
tion experiment.
Effect of oral rehydration therapy on mortality in calves
infected with serovar Typhimurium. To determine whether
mortality in calves could be prevented by oral rehydration,
eight calves, each infected with 1010 CFU of strain IR715 (wild
type), were treated using oral rehydration therapy (four calves)
or were not treated (four calves). The sodium concentration in
blood samples collected before and 1 day after infection were
determined. All calves infected with IR715 developed lethal
signs of disease and were euthanized, regardless of whether
oral rehydration therapy was performed. The observed
changes in sodium concentrations of treated or untreated
calves overlapped over a wide range (Fig. 3). Despite an in-
crease (relative to preinfection values) in sodium concentra-
tions observed in two of the calves rehydrated orally, these
animals developed lethal signs of disease and were euthanized
1 day postinfection. Thus, oral rehydration therapy practiced
as described above did not reduce mortality during experimen-
tal infection.
DISCUSSION
Serovar Typhimurium requires a functional invasion-associ-
ated type III secretion apparatus to cause diarrhea and mor-
tality in calves. For instance, mutations in hilA, encoding an
activator of SPI-1 genes (2), or prgH, encoding a component of
the type III secretion complex (21, 25), result in marked at-
tenuation and strongly reduced diarrhea during oral infection
of calves (38). Furthermore, a mutation in sspB (sipB) causes a
dramatic reduction in fluid secretion and polymorphonuclear
cell influx elicited by serovar Dublin in bovine ligated ileal
loops (12). SspB is part of a translocation complex (formed by
SspB, SspC, and SspD) which is required for the delivery of
effector proteins into the eukaryotic cytoplasm (8, 11, 12, 15,
42). Consistent with a role of SPI-1 in enteropathogenicity, we
found that mutations which prevent type III secretion
(prgHIJK) or translocation of effector proteins into host cells
(sspB, sspC, or sspD) reduced the severity of diarrhea and
resulted in marked attenuation of serovar Typhimurium during
oral infection of calves (Fig. 1). These data confirmed that
delivery of one or several translocated effector proteins by the
invasion-associated type III secretion system is required for
enteropathogenicity in calves. To assess the contribution of
individual effector proteins encoded by SPI-1 to enteropatho-
genicity, we determined the calf virulence of serovar Typhi-
murium sspA and sptP mutants.
Three of four calves infected with the serovar Typhimurium
sptP mutant and all calves inoculated with its isogenic parent
developed terminal signs of disease and were euthanized.
Thus, mutational inactivation of sptP did not result in overt
attenuation. In contrast, all calves inoculated with the serovar
Typhimurium sspA mutant (EE633) survived an infection (Fig.
1). Mutational inactivation of sspA does not result in an obvi-
ous invasion defect in tissue culture cells (17, 18), although
entry is delayed at early time points (44). Similarly, a mutation
in sspA did not result in a competitive colonization defect for
bovine Peyer’s patches, ileum, or mesenteric lymph node (Fig.
2). Furthermore, colonization of bovine tissues by the sspA
mutant resulted in intestinal lesions similar to those observed
in calves infected with its isogenic parent. Despite its inability
to produce lethal morbidity, calves infected with the sspA mu-
tant developed severe diarrhea. Measurement of the plasma
sodium concentration of infected calves suggested that the
diarrhea-induced electrolyte loss produced by a serovar Typhi-
murium sspA mutant was similar to that observed in animals
infected with the isogenic parent (Fig. 1). Significantly, these
results suggest that the loss of fluids and electrolytes may not
be the sole cause of death during bovine enteritis. It has been
speculated that mortality in calves may be caused by massive
bacterial growth leading to septicemia (33), and this possibility
cannot be ruled out. We were, however, unable to detect evi-
dence for endotoxic shock by determining concentrations of
circulating endotoxin in blood samples taken from moribund
calves infected with serovar Typhimurium (data not shown).
SspA is an effector protein which binds and stabilizes actin
filaments and modulates the actin-bundling activity of T-plas-
tin, resulting in a more pronounced outward extension of se-
rovar Typhimurium-induced membrane ruffles in epithelial
cells in vitro (44, 45). There is currently no obvious connection
between this in vitro observation and the role of SspA in
causing lethal morbidity in calves. Mutational inactivation of
sspA does not result in attenuation of serovar Typhimurium in
the mouse typhoid model, in which diarrhea does not develop
(18). Thus, the virulence defect in calves caused by a mutation
in sspA was not predicted by results obtained using either the
mouse or tissue culture model of serovar Typhimurium infec-
tion. These findings illustrate the importance of using an ani-
mal model, which resembles the natural course of infection
and the typical signs of disease, to elucidate serovar Typhi-
murium virulence mechanisms important for morbidity and
mortality during diarrheal disease.
FIG. 3. Effect of oral rehydration therapy on plasma concentrations of total
calcium (top) and sodium (bottom). Graphs show the difference in the plasma
concentrations determined for samples collected 1 day postinfection relative to
a preinfection sample. Each circle represents data from an individual animal.
Open circles indicate plasma values which were within the normal range of 133
to 143 mM (sodium) or 9.1 to 10.6 mg/dl (total calcium); closed circles indicate
plasma values outside the normal range.
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